Skip to main content
. Author manuscript; available in PMC: 2015 Dec 30.
Published in final edited form as: Pediatr Neurol. 2014 Jul 28;51(5):669–674.e5. doi: 10.1016/j.pediatrneurol.2014.07.028

TABLE 1.

Detailed Demographic and Clinical Data for Niemann-Pick Disease Type C Patients (n = 39)

Patient Sex Age Total SS Presenting Symptom Age at First Symptom (mo) Duration of Neurological Symptoms (yr) Miglustat (+/−) CoQ10 (+/−)
1 F 21.2 35 Splenomegaly 18 12.2 +
2 M 7.7 5 Splenomegaly 6 2.7 + +
3 F 13.1 33 Splenomegaly 8 11.1 +
4 M 5 11 Jaundice, splenomegaly 0 2.0
5 M 10 14 Splenomegaly 12 7.0 +
6 M 16.3 18 Hepatosplenomegaly 18 13.3 +
7 F 11.8 22 Splenomegaly 2 10.3 +
8 F 4 26 Splenomegaly 6 2.0 + +
9 M 7.7 7 Jaundice, Splenomegaly 0.5 5.7 + +
10 M 11.8 18 Splenomegaly 18 5.8 + +
11 M 5.4 8 Hepatosplenomegaly 3 3.4 + +
12 F 5.2 13 Hepatosplenomegaly 0 4.2 + +
13 M 4.7 2 Jaundice, splenomegaly 0 Unknown + +
14 M 6.1 7 Hepatosplenomegaly, jaundice 0.75 4.1 +
15 F 3.8 3 Splenomegaly 24 1.7 +
16 F 21.5 35 Vertical gaze palsy 60 16.5 +
17 F 6.7 40 Fine motor ataxia 36 3.7 +
18 F 15.7 1 Splenomegaly 24 Unknown + +
19 F 6.8 27 Fetal ascites 0 5.3 + +
20 F 12.6 24 Developmental delay 60 7.6 +
21 F 16.8 23 Learning delay Unknown 8.8 + +
22 M 8.4 46 Clumsy 18 6.9 +
23 M 1 1 Jaundice 0 Unknown + +
24 M 1.6 4 Jaundice 1.25 Unknown +
25 M 17.2 10 Unsteady gait 144 5.2 + +
26 F 8.1 8 Splenomegaly 15 1.1 + +
27 M 20.3 14 Cognitive decline, slurred speech 156 7.3 +
28 M 6.6 13 Fetal ascites 0 3.1 +
29 M 4 2 Jaundice, HSM 0 Unknown
30 F 12.7 17 Learning disability 96 4.7 +
31 F 21 18 Hepatosplenomegaly 48 16.0
32 F 15.6 12 Fetal ascites 0 Unknown +
33 M 17.2 19 Nonverbal learning disability 72 11.2
34 F 21.9 18 Learning difficulty 132 10.9
35 F 17.3 15 Clumsy 84 10.2 +
36 F 13.3 13 Learning disability 84 6.3 +
37 M 15.2 33 Seizures 72 9.2 +
38 F 11.8 16 Hepatosplenomegaly 7 8.7 +
39 M 3.8 2 Splenomegaly 6 1.7 +

Abbreviations:

F = Female

HSM = hepatosplenomegaly

M = Male

SS = National Institutes of Health Niemann-Pick disease type C neurological severity score

Duration of neurological symptoms is “unknown” when presenting symptom reported was not neurological, and onset of neurological symptom was not reported.